Searching map area
Y
Y
N
N
Y
Y
N
N
Home
Map
Random
Lists
Rate Things
Swipe
Games
Explore
Everything
Film
TV
Music
Books
Games
People
Characters
Places
Food
Life
Ideas
Organizations
Schools
Posts
News
Memes
Flags
Papers
Art
Space
Chemistry
Technology
Events
Emoji
Instruments
Other
Join YYNN
Sign in
Giuseppe Saglio
?
TBD
Italian clinical immunologist, hematologist and researcher
Join to rate
Ratings
About
Ratings
0
Nobody has rated this yet. Be the first!
Works
10
Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia
article by Simona Soverini et al published 15 December 2006 in Clinical Cancer Research
Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party
article by Gabriele Gugliotta et al published 26 May 2011 in Blood
Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis
scientific article
Modeling myeloproliferative neoplasms: From mutations to mouse models and back again
scientific article published on 24 November 2016
Presence or the emergence of a F317L BCR-ABL mutation may be associated with resistance to dasatinib in Philadelphia chromosome-positive leukemia
scientific article published on 01 November 2006
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party o
article by Simona Soverini et al published 20 June 2005 in Journal of Clinical Oncology
Mechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 Complex
scientific article published on 29 November 2016
Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion
scientific article
Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain
scientific article published on 01 March 2007
Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study
scientific article
Lists
0
Join to rate
Instance of
Human
Occupation
Researcher
immunologist
Wikidata